Who founded Novuson Surgical?

Novuson Surgical was founded by Stuart B. Mitchell in 2014.

Who are Novuson Surgical's investors?

Novuson Surgical's investors include Keiretsu Forum.

How much funding has Novuson Surgical raised?

Novuson Surgical has disclosed $2.9M raised across 2 rounds.

Where is Novuson Surgical headquartered?

Novuson Surgical is headquartered in Bothell, US.

Novuson Surgical

Bothell, US · Founded 2014 · 1 known investors

Find your way into Novuson Surgical

Paths you didn't know you had: your email and LinkedIn already hold routes to the Novuson Surgical team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NOVUSON develops biomedical instrumentation and medical devices, serving healthcare organizations and clinical environments. The company focuses on innovative medical technology across biomechanics, tissue engineering, and surgical device platforms.

Biotech Deep Tech Hardware Healthtech Medical Devices

Founders & leadership

Novuson Surgical was founded in 2014 by Stuart B. Mitchell.

Stuart B. MitchellCEO, Founder and Chief Science OfficerStuart B. Mitchell is CEO and Chief Science Officer of Novuson, which develops biomedical instrumentation and medical devices. He holds expertise in mechanical engineering, bioengineering, biomechanics, and tissue engineering, with background experience developing bioreactors, medical devices, and surgical instruments in academic and industry settings.

Francesco P CurraExecutive

Christoph E MackExecutive

Investors · 1

Keiretsu Forumlisted by Keiretsu ForumSan Francisco East Bay · $250K – $2M

How we know: Keiretsu Forum's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2.9M disclosed across 2 rounds · 2015–2017

▶$2.4MraisedMar 2020 · 29 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Stuart B MitchellExecutive Officer, Director

Offering amount: $3M
Amount sold: $2.4M
Minimum investment: $50K
First sale: Sep 2017
Incorporated: Corporation, Washington
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$500KraisedOct 2015 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Francesco P CurraExecutive Officer, Director
Christoph E MackExecutive Officer, Director
Stuart B MitchellExecutive Officer, Director

Offering amount: $5.8M
Amount sold: $500K
Minimum investment: $25K
Placement agents: Novuson Surgical, Inc.
First sale: Oct 2015
Incorporated: Corporation, Washington, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.

Sonex HealthSonex Health develops ultrasound-guided medical devices for orthopedic conditions, including UltraGuideCTR, a device that enables carpal tunnel release to be performed in a clinic setting. The company targets physicians and healthcare providers seeking minimally invasive treatments with faster patient recovery.

Noleus TechnologiesNoleus Technologies develops medical device technologies to reduce post-surgical swelling and tissue fluid overload that delay patient recovery. The company's lead product targets post-operative ileus to accelerate bowel function restoration after abdominal surgery.

BioventusBioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures. The company serves healthcare providers and patients seeking clinically effective, cost-efficient alternatives to traditional treatments.

Companies working in the same space as Novuson Surgical.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2016	$1.5M
National Institutes of Health (NIH)National Institutes of Health	Phase II	2016	$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Novuson® Surgical Secures Funding from HOYA Corporation - BioSpacebiospace.com · May 2019

Frequently asked questions

What does Novuson Surgical do?: NOVUSON develops biomedical instrumentation and medical devices, serving healthcare organizations and clinical environments. The company focuses on innovative medical technology across biomechanics, tissue engineering, and surgical device platforms.
Who founded Novuson Surgical?: Novuson Surgical was founded by Stuart B. Mitchell in 2014.
Who are Novuson Surgical's investors?: Novuson Surgical's investors include Keiretsu Forum.
How much funding has Novuson Surgical raised?: Novuson Surgical has disclosed $2.9M raised across 2 rounds.
Where is Novuson Surgical headquartered?: Novuson Surgical is headquartered in Bothell, US.